Quhill, Fahd, and Annette Beiderbeck. 2017. “Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN®) Versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema”. Global and Regional Health Technology Assessment 4 (1):155-64. https://doi.org/10.33393/grhta.2017.391.